Loading…
Identification and characterization of a cytotoxic T cell epitope of hepatitis C virus presented by HLA-B3501 in acute hepatitis
M Ibe, T Sakaguchi, K Tanaka, S Saito, S Yokota, T Tanaka, K Shimotohno, Y Chujoh, Y Shiratori, M Omata, K Miwa and M Takiguchi Department of Tumour Biology, Institute of Medical Science, University of Tokyo, Japan. In order to clarify the role of cytotoxic T lymphocytes (CTL) in hepatitis C virus (...
Saved in:
Published in: | Journal of general virology 1998-07, Vol.79 (7), p.1735-1744 |
---|---|
Main Authors: | , , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | M Ibe, T Sakaguchi, K Tanaka, S Saito, S Yokota, T Tanaka, K Shimotohno, Y Chujoh, Y Shiratori, M Omata, K Miwa and M Takiguchi
Department of Tumour Biology, Institute of Medical Science, University of Tokyo, Japan.
In order to clarify the role of cytotoxic T lymphocytes (CTL) in hepatitis
C virus (HCV) infection, an HLA-B35-restricted cytotoxic T cell epitope of
HCV was identified using a strategy called reverse immunogenetics.
Twenty-eight of 53 HCV peptides carrying two anchor residues were selected
as HLA-B*3501 binding peptides. These peptides were used to induce the
specific cytotoxic T cells in peripheral blood lymphocytes from a patient
with acute hepatitis C. Six HLA-B*3501 binding peptides induced the
peptide-specific CTL. One (HPNIEEVAL) of five peptides was confirmed as the
epitope by the specific T cell clones. A sequence identical to the epitope
was detected in isolates of the virus from the patient and a strong CTL
response to this epitope was observed in the acute phase of hepatitis C but
not in the recovery phase. The specific CTL for this epitope were not
detected in peripheral blood lymphocytes from patients with chronic
hepatitis C. Together these results suggest that the CTL specific for this
epitope have an important role in the elimination of the virus in the
patient. |
---|---|
ISSN: | 0022-1317 1465-2099 |
DOI: | 10.1099/0022-1317-79-7-1735 |